Skip to content
← Holders

5AM Venture Management, LLC

What 5AM Venture Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1799883 · Filed Nov 16, 2026

Positions
16
Reported value
$297M
Opened
2
Closed
2
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$273M
    25 positions
  2. Dec 31, 2025$318.1M
    21 positions
  3. Mar 31, 2026$360.2M
    20 positions
  4. Jun 30, 2026$287.9M
    16 positions
  5. Sep 30, 2026$297M
    16 positions
SecuritySharesChangeValueOf portfolio
LTGOLatigo Biotherapeutics, Inc.
7.3MNew$122.3M41.2%
TRDAEntrada Therapeutics, Inc.
3.8M−6.7%$24M8.1%
TYRATyra Biosciences, Inc.
1M±0%$22.5M7.6%
CAMPCamp4 Therapeutics Corp
5.3M−10.1%$21.3M7.2%
ARTVArtiva Biotherapeutics, Inc.
2.4M±0%$16.8M5.6%
PHVSPharvaris N.V.
479.9K−39.8%$15.2M5.1%
TECXTectonic Therapeutic, Inc.
606.7K±0%$14.1M4.8%
CLDXCelldex Therapeutics, Inc.
422.3K−15.1%$13.7M4.6%
ZNTLZentalis Pharmaceuticals, Inc.
3.9M±0%$10.9M3.7%
BHVNBiohaven Ltd.
739K±0%$9.9M3.3%
MPLTMapLight Therapeutics, Inc.
741.9K−21.9%$7.6M2.5%
SLNSilence Therapeutics plc
476.2K±0%$5.2M1.8%
ALXOALX Oncology Holdings Inc
3.1M±0%$4.2M1.4%
TARAProtara Therapeutics, Inc.
1.4M±0%$4.2M1.4%
EYPTEyePoint, Inc.
1.1M±0%$3.4M1.2%
SKYESkye Bioscience, Inc.
981.3KNew$1.6M0.5%